Europe Veterinary Pharmaceuticals Market Size, Share & Trends Report

Europe Veterinary Pharmaceuticals Market Size, Share & Trends Analysis Report By Animal Type (Companion Animals, Livestock Animals), By Mode Of Administration, By Product, By Distribution Channel, By Country, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68039-629-7
  • Number of Pages: 140
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                     1.1. Market Segmentation & Scope
                         1.1.1. Animal type
                         1.1.2. Product
                         1.1.3. Mode of administration
                         1.1.4. Distribution channel
                         1.1.5. Regional scope
                         1.1.6. Estimates and forecast timeline
                     1.2. Research Methodology
                     1.3. Information Procurement
                         1.3.1. Purchased database
                         1.3.2. GVR’s internal database
                         1.3.3. Secondary sources
                         1.3.4. Primary research
                         1.3.5. Details of primary research
                     1.4. Information or Data Analysis
                     1.5. Market Formulation & Validation
                     1.6. Model Details
                     1.7. List of Secondary Sources
                     1.8. List of Primary Sources
                     1.9. Objectives
Chapter 2. Executive Summary
                     2.1. Market Outlook
                     2.2. Segment Outlook
                         2.2.1. Animal type outlook
                         2.2.2. Product outlook
                         2.2.3. Mode of administration outlook
                         2.2.4. Distribution channel outlook
                         2.2.5. Regional outlook
                     2.3. Competitive Insights
Chapter 3. Europe Veterinary Pharmaceuticals Market Variables, Trends & Scope
                     3.1. Market Lineage Outlook
                         3.1.1. Parent market outlook
                         3.1.2. Related/ancillary market outlook
                     3.2. Penetration & Growth Prospect Mapping
                     3.3. Industry Value Chain Analysis
                         3.3.1. Reimbursement framework
                     3.4. Market Dynamics
                         3.4.1. Market Driver Analysis
                         3.4.2. Market Restraint Analysis
                     3.5. Europe Veterinary Pharmaceuticals Market Analysis Tools
                         3.5.1. Industry Analysis - Porter’s
                             3.5.1.1. Supplier power
                             3.5.1.2. Buyer power
                             3.5.1.3. Substitution threat
                             3.5.1.4. Threat of new entrant
                             3.5.1.5. Competitive rivalry
                         3.5.2. PESTEL Analysis
                             3.5.2.1. Political landscape
                             3.5.2.2. Technological landscape
                             3.5.2.3. Economic Landscape
Chapter 4. Europe Veterinary Pharmaceuticals: Animal Type Estimates & Trend Analysis
                     4.1. Europe Veterinary Pharmaceuticals Market: Key Takeaways
                     4.2. Europe Veterinary Pharmaceuticals Market: Movement & Market Share Analysis, 2022 & 2030
                     4.3. Companion Animals
                         4.3.1. Companion animals market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.3.2. Dogs
                             4.3.2.1. Dogs market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.3.3. Cats
                             4.3.3.1. Cats market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.3.4. Horses
                             4.3.4.1. Horses market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.3.5. Others (Small Mammals, Birds)
                             4.3.5.1. Others (small mammals, birds) market estimates and forecasts, 2018 to 2030 (USD Million)
                     4.4. Livestock Animals
                         4.4.1. Livestock animals market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.4.2. Pigs
                             4.4.2.1. Pigs market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.4.3. Cattle
                             4.4.3.1. Cattle market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.4.4. Sheep & Goats
                             4.4.4.1. Sheep & goats market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.4.5. Others (Poultry, Aquatics)
                             4.4.5.1. Others (poultry, aquatics) market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Europe Veterinary Pharmaceuticals: Product Estimates & Trend Analysis
                     5.1. Europe Veterinary Pharmaceuticals Market: Key Takeaways
                     5.2. Europe Veterinary Pharmaceuticals Market: Movement & Market Share Analysis, 2022 & 2030
                     5.3. Parasiticides
                         5.3.1. Parasiticides market estimates and forecasts, 2018 to 2030 (USD Million)
                     5.4. Anti-infectives
                         5.4.1. Anti-infectives market estimates and forecasts, 2018 to 2030 (USD Million)
                     5.5. Anti-inflammatory
                         5.5.1. Anti-inflammatory market estimates and forecasts, 2018 to 2030 (USD Million)
                     5.6. Analgesics
                         5.6.1. Analgesics market estimates and forecasts, 2018 to 2030 (USD Million)
                     5.7. Others
                         5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million
Chapter 6. Europe Veterinary Pharmaceuticals: Mode of Administration Estimates & Trend Analysis
                     6.1. Europe Veterinary Pharmaceuticals Market: Key Takeaways
                     6.2. Europe Veterinary Pharmaceuticals Market: Movement & Market Share Analysis, 2022 & 2030
                     6.3. Oral
                         6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
                     6.4. Parenteral
                         6.4.1. Parenteral market estimates and forecasts, 2018 to 2030 (USD Million)
                     6.5. Topical
                         6.5.1. Topical market estimates and forecasts, 2018 to 2030 (USD Million)
                     6.6. Others (Inhalation, Carrier)
                         6.6.1. Others (inhalation, carrier) market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Europe Veterinary Pharmaceuticals: Distribution Channel Estimates & Trend Analysis
                     7.1. Europe Veterinary Pharmaceuticals Market: Key Takeaways
                     7.2. Europe Veterinary Pharmaceuticals Market: Movement & Market Share Analysis, 2022 & 2030
                     7.3. Veterinary Hospitals & Clinics
                         7.3.1. Veterinary hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
                     7.4. Pharmacies & retail stores
                         7.4.1. Pharmacies & retail stores market estimates and forecasts, 2018 to 2030 (USD Million)
                     7.5. Digital or E-commerce
                         7.5.1. Digital or e-commerce market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Europe Veterinary Pharmaceuticals Market: Country Estimates & Trend Analysis
                     8.1. Regional Outlook
                     8.2. Europe Veterinary Pharmaceuticals Market by Region: Key Takeaway
                     8.3. Europe
                         8.3.1. UK
                             8.3.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.2. Germany
                             8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.3. France
                             8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.4. Italy
                             8.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.5. Spain
                             8.3.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.6. Poland
                             8.3.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.7. Netherlands
                             8.3.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.8. Hungary
                             8.3.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.9. Denmark
                             8.3.9.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.10. Sweden
                             8.3.10.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                         8.3.11. Portugal
                             8.3.11.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
                     9.1. Recent Developments & Impact Analysis, By Key Market Participants
                     9.2. Market Participant Categorization
                         9.2.1. Merck & Co., Inc.,
                             9.2.1.1. Company overview
                             9.2.1.2. Financial performance
                             9.2.1.3. Product benchmarking
                             9.2.1.4. Strategic initiatives
                         9.2.2. Ceva
                             9.2.2.1. Company overview
                             9.2.2.2. Financial performance
                             9.2.2.3. Product benchmarking
                             9.2.2.4. Strategic initiatives
                         9.2.3. Vetoquinol
                             9.2.3.1. Company overview
                             9.2.3.2. Financial performance
                             9.2.3.3. Product benchmarking
                             9.2.3.4. Strategic initiatives
                         9.2.4. Zoetis Services LLC
                             9.2.4.1. Company overview
                             9.2.4.2. Financial performance
                             9.2.4.3. Product benchmarking
                             9.2.4.4. Strategic initiatives
                         9.2.5. Boehringer Ingelheim International GmbH
                             9.2.5.1. Company overview
                             9.2.5.2. Financial performance
                             9.2.5.3. Product benchmarking
                             9.2.5.4. Strategic initiatives
                         9.2.6. Elanco
                             9.2.6.1. Company overview
                             9.2.6.2. Financial performance
                             9.2.6.3. Product benchmarking
                             9.2.6.4. Strategic initiatives
                         9.2.7. Virbac
                             9.2.7.1. Company overview
                             9.2.7.2. Financial performance
                             9.2.7.3. Product benchmarking
                             9.2.7.4. Strategic initiatives
                         9.2.8. Calier
                             9.2.8.1. Company overview
                             9.2.8.2. Financial performance
                             9.2.8.3. Product benchmarking
                             9.2.8.4. Strategic initiatives
                         9.2.9. Bimeda Corporate
                             9.2.9.1. Company overview
                             9.2.9.2. Financial performance
                             9.2.9.3. Product benchmarking
                             9.2.9.4. Strategic initiatives
                         9.2.10. Prodivet Pharmaceuticals SA/NV
                             9.2.10.1. Company overview
                             9.2.10.2. Financial performance
                             9.2.10.3. Product benchmarking
                             9.2.10.4. Strategic initiatives


List of Tables

Table 1 List of Abbreviations
Table 2 Europe veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 3 Europe veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 4 Europe veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 5 Europe veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 6 Europe veterinary pharmaceuticals market, by region, 2018 - 2030 (USD Million)
Table 7 UK veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 8 UK veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 9 UK veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 10 UK veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Germany veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 12 Germany veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 13 Germany veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 14 Germany veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 15 France veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 16 France veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 17 France veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 18 France veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Italy veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 20 Italy veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 21 Italy veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 22 Italy veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 23 Spain veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 24 Spain veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 25 Spain veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 26 Spain veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 27 Poland veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 28 Poland veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 29 Poland veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 30 Poland veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 31 Netherland veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 32 Netherland veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 33 Netherland veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 34 Netherland veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 35 Hungary veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 36 Hungary veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 37 Hungary veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 38 Hungary veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 39 Denmark veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 40 Denmark veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 41 Denmark veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 42 Denmark veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 43 Sweden veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 44 Sweden veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 45 Sweden veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 46 Sweden veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)
Table 47 Portugal veterinary pharmaceuticals market, by animal type, 2018 - 2030 (USD Million)
Table 48 Portugal veterinary pharmaceuticals market, by product, 2018 - 2030 (USD Million)
Table 49 Portugal veterinary pharmaceuticals market, by mode of administration, 2018 - 2030 (USD Million)
Table 50 Portugal veterinary pharmaceuticals market, by distribution channel, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Europe veterinary pharmaceuticals: Market outlook
Fig. 9 Europe veterinary pharmaceuticals: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Europe veterinary pharmaceuticals market driver impact
Fig. 15 Europe veterinary pharmaceuticals market restraint impact
Fig. 16 Europe veterinary pharmaceuticals market strategic initiatives analysis
Fig. 17 Europe veterinary pharmaceuticals market: Animal Type movement analysis
Fig. 18 Europe veterinary pharmaceuticals market: Animal Type outlook and key takeaways
Fig. 19 Companion animals market estimates and forecasts, 2018 - 2030
Fig. 20 Livestock animals market estimates and forecasts, 2018 - 2030
Fig. 21 Europe veterinary pharmaceuticals market: Product movement analysis
Fig. 22 Europe veterinary pharmaceuticals market: Product outlook and key takeaways
Fig. 23 Parasiticides market estimates and forecasts, 2018 - 2030
Fig. 24 Anti-infectives market estimates and forecasts, 2018 - 2030
Fig. 25 Anti-inflammatory market estimates and forecasts, 2018 - 2030
Fig. 26 Analgesics market estimates and forecasts, 2018 - 2030
Fig. 27 Others market estimates and forecasts, 2018 - 2030
Fig. 28 Europe veterinary pharmaceuticals market: Mode of Administration movement analysis
Fig. 29 Europe veterinary pharmaceuticals market: Mode of Administration outlook and key takeaways
Fig. 30 Oral market estimates and forecasts, 2018 - 2030
Fig. 31 Parenteral market estimates and forecasts, 2018 - 2030
Fig. 32 Topical market estimates and forecasts, 2018 - 2030
Fig. 33 Others (inhalation, carrier) market estimates and forecasts, 2018 - 2030
Fig. 34 Europe veterinary pharmaceuticals market: Mode of Administration movement analysis
Fig. 35 Europe veterinary pharmaceuticals market: Mode of Administration outlook and key takeaways
Fig. 36 Veterinary hospitals & clinics market estimates and forecasts, 2018 - 2030
Fig. 37 Pharmacies & Retail Stores market estimates and forecasts, 2018 - 2030
Fig. 38 Digital or e-commerce market estimates and forecasts, 2018 - 2030
Fig. 39 Europe veterinary pharmaceuticals market: Country movement analysis
Fig. 40 Europe veterinary pharmaceuticals market: Country outlook and key takeaways
Fig. 41 Europe. market estimates and forecasts, 2018 - 2030
Fig. 42 UK market estimates and forecasts, 2018 - 2030
Fig. 43 Germany market estimates and forecasts, 2018 - 2030
Fig. 44 France market estimates and forecasts, 2018 - 2030
Fig. 45 Italy market estimates and forecasts, 2018 - 2030
Fig. 46 Spain market estimates and forecasts, 2018 - 2030
Fig. 47 Poland market estimates and forecasts, 2018 - 2030
Fig. 48 Netherland market estimates and forecasts, 2018 - 2030
Fig. 49 Hungary market estimates and forecasts, 2018 - 2030
Fig. 50 Denmark market estimates and forecasts, 2018 - 2030
Fig. 51 Sweden market estimates and forecasts, 2018 - 2030
Fig. 52 Poland market estimates and forecasts, 2018 - 2030

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon